Hayward, California, August 26th 2015 – RayVio Corporation, the world leader in the development and commercialization of deep ultraviolet (UV) LEDs and integrated solutions, announced today that they are expanding their international sales force, and manufacturing capacity to support increased customer demands. The facility expansion at the original site is scheduled to be complete by year-end.
RayVio’s current Silicon Valley headquarters houses their wafer growth, chip fabrication, packaging and test R&D and proto-typing capability. The expansion of this facility will enable RayVio to reduce cycle time and produce in excess of two million LED units annually through the installation of additional manufacturing and test equipment. Combined with its contract manufacturing strategy, RayVio is poised to keep pace with the increasing demand of the fast growing deep UV LED market.
The demand is being driven by a host of industrial and consumer applications ranging from water disinfection to consumer medical devices serving multiple global markets. With the demonstration of power levels up to 45mW from a single emitter device, and multi-chip offerings capable of delivering much higher power, RayVio’s complete product suite is tailored to meet the demanding needs of all UV customers and applications.
“Our proven, novel technology platform is producing best in class performance, and at the same time we are executing against our cost reduction roadmap, allowing our downstream partners to make their products a reality” says Dr. Doug Collins, Vice President of Engineering and Operations.
Until recent achievements in both performance and cost, UV LED solutions were limited to niche applications. With the availability of high optical power UV LEDs, and competitive system level pricing to alternative UV sources, the UV LED industry is seeing a major uptake in solutions being provided.
“RayVio’s superior performance and cost effective solutions have accelerated the mass adoption of UV LED enabled industrial and consumer devices,” says Dr. Robert C. Walker, RayVio co-founder and CEO. “With the funding we received earlier this year, we have the capital required to grow the company aggressively. By expanding our international sales force and increasing our manufacturing and research capabilities, we will be well positioned to maintain a leadership role.”
RayVio came out of stealth mode at the beginning of 2015 after closing their $9.3M series B round of financing. They are currently sampling selected customers, and are working closely with industry leading partners in the UV LED curing, medical device and water, surface and air disinfection markets.
RayVio is transforming how we use UV today by offering consumer disinfection solutions that are higher performance, require less power, are portable, durable, and cost effective.
RayVio’s patent protected UV LED technology and materials, originally developed at Boston University by co-founders Dr. Yitao Liao and Prof. Theodore Moustakas, are highly differentiated, delivering performance at price points which are enabling the mass adoption of UV LED solutions in the industrial, commercial and consumer sectors.
RayVio’s novel UV LED technology will make possible the highest performance, most cost effective solutions for industrial curing, for UV medical treatment devices to treat ailments ranging from vitamin D deficiency to Multiple Sclerosis, and for the UV water, surface and air disinfection markets.
To learn more about RayVio please visit us at www.rayvio.com
For additional information contact:
Dr. Robert C. Walker